Skip to main content
Equibles
RGNX logo

RGNX · REGENXBIO Inc. · Analyst Estimates

Track RGNX — free

Use RGNX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RGNX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.56 -0.17 (-1.95%) At close · Sep 10
Russell 2000 member Rebalance outlook locked
Going-concern doubt — cleared Aug 6, 2026

The latest filing no longer states the doubt (first flagged May 14, 2026).

View the 10-Q filed Aug 6, 2026
Market Cap
$576.30M
Shares
66.01M

Analyst Estimates

Compare analyst forecasts for REGENXBIO Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1590877 CUSIP 75901B107 13F (30d) 99 filings 99 filers Visit website Investor relations